Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon

被引:80
作者
Cai, Rui [1 ]
Cheng, Chen [1 ]
Chen, Jianwei [2 ]
Xu, Xiaoqiang [3 ]
Ding, Chao [4 ,5 ]
Gu, Bing [1 ,6 ]
机构
[1] Xuzhou Med Univ, Med Technol Sch, Xuzhou, Jiangsu, Peoples R China
[2] BGI Shenzhen, BGI Qingdao, Qingdao, Peoples R China
[3] Aimigene Inst, R&D Ctr, Shenzhen, Peoples R China
[4] Nanjing Univ, Drum Tower Hosp, Med Sch, Dept Gen Surg, 321 Zhongshan Rd, Nanjing 210000, Peoples R China
[5] Nanjing Univ, Med Sch, Jinling Hosp, Dept Gen Surg, Nanjing, Peoples R China
[6] Xuzhou Med Univ, Affiliated Hosp, Dept Lab Med, 99 West Huaihai Rd, Xuzhou 221002, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
Mucus layer; mucin; commensalism; pathogen; colonization resistance; GUT MICROBIOTA; INTESTINAL BARRIER; DIETARY FIBER; MUCIN GENES; BACTERIA; COLONIZATION; DIVERSITY; INFECTION; HEALTH; IMPACT;
D O I
10.1080/19490976.2020.1735606
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The intestinal mucosal barrier, which is composed of epithelial cells and mucus layers secreted by goblet cells and contains commensal bacteria, constitutes the first line of defense against pathogenic gut microbiota. However, homeostasis between the microbiota and mucus layer is easily disrupted by certain factors, resulting in alteration of the gut microbiota and entry of pathogens to the intestinal mucosal barrier. In this review, we describe the structures and functions of the mucus layer, expound several crucial influencing factors, including diet styles, medications and host genetics, and discuss how pathogenic microorganisms interact with the mucus layer and commensal microbiota, with the understanding that unraveling their complex interactions under homeostatic and dysbiosis conditions in the colon would help reveal some underlying pathogenic mechanisms and thus develop new strategies to prevent pathogenic microbiological colonization.
引用
收藏
页码:680 / 690
页数:11
相关论文
共 88 条
  • [11] Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut[J]. de la Cuesta-Zuluaga, Jacobo;Mueller, Noel T.;Corrales-Agudelo, Vanessa;Velasquez-Mejia, Eliana P.;Carmona, Jenny A.;Abad, Jose M.;Escobar, Juan S. DIABETES CARE, 2017(01)
  • [12] Microbial biofilms and the human intestinal microbiome[J]. de Vos, Willem M. NPJ BIOFILMS AND MICROBIOMES, 2015
  • [13] Modulation of the Gastrointestinal Microbiome with Nondigestible Fermentable Carbohydrates To Improve Human Health[J]. Deehan, Edward C.;Duar, Rebbeca M.;Armet, Anissa M.;Perez-Munoz, Maria Elisa;Jin, Mingliang;Walter, Jens. MICROBIOLOGY SPECTRUM, 2017(05)
  • [14] Akkermansia muciniphila and its role in regulating host functions[J]. Derrien, Muriel;Belzer, Clara;de Vos, Willem M. MICROBIAL PATHOGENESIS, 2017
  • [15] A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility[J]. Desai, Mahesh S.;Seekatz, Anna M.;Koropatkin, Nicole M.;Kamada, Nobuhiko;Hickey, Christina A.;Wolter, Mathis;Pudlo, Nicholas A.;Kitamoto, Sho;Terrapon, Nicolas;Muller, Arnaud;Young, Vincent B.;Henrissat, Bernard;Wilmes, Paul;Stappenbeck, Thaddeus S.;Nunez, Gabriel;Martens, Eric C. CELL, 2016(05)
  • [16] Mucins: Structural diversity, biosynthesis, its role in pathogenesis and as possible therapeutic targets[J]. Dhanisha, Suresh Sulekha;Guruvayoorappan, Chandrasekharan;Drishya, Sudarsanan;Abeesh, Prathapan. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018
  • [17] Gut Microbiota-Produced Succinate Promotes C-difficile Infection after Antibiotic Treatment or Motility Disturbance[J]. Ferreyra, Jessica A.;Wu, Katherine J.;Hryckowian, Andrew J.;Bouley, Donna M.;Weimer, Bart C.;Sonnenburg, Justin L. CELL HOST & MICROBE, 2014(06)
  • [18] Interaction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort[J]. Flowers, Stephanie A.;Evans, Simon J.;Ward, Kristen M.;McInnis, Melvin G.;Ellingrod, Vicki L. PHARMACOTHERAPY, 2017(03)
  • [19] Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota[J]. Forslund, Kristoffer;Hildebrand, Falk;Nielsen, Trine;Falony, Gwen;Le Chatelier, Emmanuelle;Sunagawa, Shinichi;Prifti, Edi;Vieira-Silva, Sara;Gudmundsdottir, Valborg;Pedersen, Helle Krogh;Arumugam, Manimozhiyan;Kristiansen, Karsten;Voigt, Anita Yvonne;Vestergaard, Henrik;Hercog, Rajna;Costea, Paul Igor;Kultima, Jens Roat;Li, Junhua;Jorgensen, Torben;Levenez, Florence;Dore, Joel;Nielsen, H. Bjorn;Brunak, Soren;Raes, Jeroen;Hansen, Torben;Wang, Jun;Ehrlich, S. Dusko;Bork, Peer;Pedersen, Oluf. NATURE, 2015(7581)
  • [20] Pathogen recognition receptors, cancer and inflammation in the gut[J]. Fukata, Masayuki;Abreu, Maria T. CURRENT OPINION IN PHARMACOLOGY, 2009(06)